ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023
August 10, 2023 08:00 ET
|
ProPhase Labs, Inc.
Company believes that the combined value of its five operating units exceeds its current market capitalization and that each unit has significant growth potential. Company highlights...
ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test
March 13, 2023 08:00 ET
|
ProPhase Labs, Inc.
Presentation to be given in Collaboration with the Mayo Clinic at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting Company’s findings to be presented in a headline Poster...
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
October 17, 2022 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
ProPhase Labs to Present at the Q4 Investor Summit Conference
November 10, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
ProPhase Labs to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
September 07, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 07, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021
July 12, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announced that Chief...
ProPhase Labs Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
July 01, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, July 01, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, announced today that it has...
ProPhase Labs Added to the Russell Microcap Index
June 28, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, June 28, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announces that it has...
ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend
May 13, 2021 16:05 ET
|
ProPhase Labs, Inc.
First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business Gross Profit Increases to $8.9 Million With Net Income of $1.1 Million or $0.07 Per Share ...
ProPhase Labs to Provide COVID-19 Testing for Oyster Bay Township in New York
April 22, 2021 08:30 ET
|
ProPhase Labs, Inc.
ProPhase Labs Will Offer State-Of-The-Art Testing to Aid Oyster Bay Community in Reopening GARDEN CITY, NY, April 22, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified...